1521255-61-7 Usage
Chemical structure
The compound has a cyclopropane carboxylic acid ethyl ester group and a boron-containing phenyl compound.
Strain
The presence of the cyclopropane group gives the molecule a strained three-membered ring structure.
Chemical reactivity
The boron-containing phenyl group provides unique chemical reactivity.
Application
The compound is commonly used as a building block in organic synthesis, particularly in the pharmaceutical and agrochemical industries.
Functionalization
The compound can be functionalized and modified to create new compounds with diverse biological activities.
Directing group
The boron-containing phenyl group can serve as a directing group in metal-catalyzed transformations.
Development
The compound is particularly useful in the development of new chemical reactions and methodologies.
Check Digit Verification of cas no
The CAS Registry Mumber 1521255-61-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,2,1,2,5 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1521255-61:
(9*1)+(8*5)+(7*2)+(6*1)+(5*2)+(4*5)+(3*5)+(2*6)+(1*1)=127
127 % 10 = 7
So 1521255-61-7 is a valid CAS Registry Number.
1521255-61-7Relevant academic research and scientific papers
N-ALKYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS
-
Page/Page column 27-28, (2014/01/09)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful
N-ARYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTS
-
Page/Page column 73, (2014/01/09)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, pulmonary fibrosis
